McKesson streamlines after COVID-19

Shares of drug wholesaler McKesson have surged over 270% in the past five years. That’s largely due to its deal with the U.S. government to distribute COVID-19 vaccines. Even though the pandemic has eased, the company should continue to benefit from its plan to narrow… Read More

McKesson pivots to North America

MCKESSON CORP. $333 is a buy for aggressive investors. The company (New York symbol MCK; Aggressive Growth Portfolio, Consumer sector; Shares outstanding: 149.8 million; Market cap: $49.9 billion; Price-to-sales ratio: 0.2; Dividend yield 0.6%; TSINetwork Rating: Above Average; www.mckesson.com) recently sold its European operations so it can focus… Read More

McKesson sharpens its focus

MCKESSON CORP. $247 is a buy for aggressive investors. The company (New York symbol MCK; Aggressive Growth Portfolio, Consumer sector; Shares outstanding: 152.7 million; Market cap: $37.7 billion; Price-to-sales ratio: 0.2; Dividend yield 0.8%; TSINetwork Rating: Above Average; www.mckesson.com) is now selling its European operations (in stages) so… Read More